Left Ventricular Hypertrophy: Major Risk Factor in Patients with Hypertension: Update and Practical Clinical Applications

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Hypertension</td><td align="center"></td></tr><tr><td align="left">Neurohumoral factors (growth stimulation)</td><td align="center"></td></tr><tr><td align="left"> Angiotensin II</td><td align="center"></td></tr><tr><td align="left"> Aldosterone</td><td align="center"></td></tr><tr><td align="left"> Norepinephrine</td><td align="center"></td></tr><tr><td align="left"> Insulin and other growth factors</td><td align="center"></td></tr><tr><td align="left">Genetic influences</td><td align="center"></td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Factors promoting left ventricular hypertrophy.

International Journal of Hypertension

tab1

Table 1

Table 1: Left Ventricular Hypertrophy: Major Risk Factor in Patients with Hypertension: Update and Practical Clinical Applications 